EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric‐onset drug‐resistant epilepsy

Samuel Ahn iD, Benjamin Edmonds iD, Rajsekar R Rajaraman, Lekha M Rao iD, Shaun A Hussain iD, Joyce H Matsumoto iD, Raman Sankar iD, Noriko Salamon iD, Aria Fallah iD, Hiroki Nariai iD

Epilepsia · 2024-08 · 65 (8)

DOI: 10.1111/epi.18031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 07.06.2024. Verfasst von Samuel Ahn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine, Los Angeles, California,…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Intralaminar Thalamic Nuclei. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Elsie and Isaac Fogelman Endowment, Dr Alfonsina Q. Davies Endowed Chair for Epilepsy Research, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromodulation therapies offer an efficacious treatment alternative for patients with drug‐resistant epilepsy (DRE), particularly those unlikely to benefit from surgical resection. Here we present our retrospective single‐center case series of patients with pediatric‐onset DRE who underwent responsive neurostimulation (RNS) depth electrode implantation targeting the bilateral centromedian nucleus (CM) of the thalamus between October 2020 and October 2022. Sixteen patients were identified; seizure outcomes, programming parameters, and complications at follow‐up were reviewed. The median age at implantation was 13 years (range 3.6–22). Six patients (38%) were younger than 12 years of age at the time of implantation. Ictal electroencephalography (EEG) patterns during patients’ most disabling seizures were reliably detected. Ten patients (62%) achieved 50% or greater reduction in seizure frequency at a median 1.3 years (range 0.6–2.6) of follow‐up. Eight patients (50%) experienced sensorimotor side effects, and three patients (19%) had superficial pocket infection, prompting the removal of the RNS device. Side effects of stimulation were experienced mostly in monopolar‐cathodal configuration and alleviated with programming change to bipolar configuration or low‐frequency stimulation. Closed‐loop neurostimulation using RNS targeting bilateral CM is a feasible and useful therapy for patients with pediatric‐onset DRE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyIntralaminar Thalamic NucleiHumansChildFemaleMaleAdolescentRetrospective StudiesChild, PreschoolYoung AdultDeep Brain StimulationElectroencephalographyTreatment OutcomeElectrodes, ImplantedImplantable Neurostimulators

Stichwörter der Autor:innen

centromedian nucleusdrug‐resistant epilepsyepilepsy surgeryneurostimulationthalamus

Autor:innen und Institutionen

  • Division of Pediatric Neurology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine, Los Angeles, California, USA.
  • Division of Pediatric Neurology, Department of Neurology, Seattle Children's Hospital, Seattle, Washington, USA.
  • Department of Radiological Sciences, University of California, Los Angeles, California, USA.
  • Department of Neurosurgery, UCLA Medical Center, David Geffen School of Medicine, Los Angeles, California, USA.
  • The UCLA Children's Discovery and Innovation Institute, Los Angeles, California, USA.

ORCID-Profile: Samuel Ahn, Benjamin Edmonds, Lekha M Rao, Shaun A Hussain, Joyce H Matsumoto, Raman Sankar, Noriko Salamon, Aria Fallah, Hiroki Nariai

Förderung

  • Elsie and Isaac Fogelman Endowment
  • Dr Alfonsina Q. Davies Endowed Chair for Epilepsy Research
  • NINDS NIH HHS
  • Sudha Neelakantan & Venky Harinarayan Charitable Fund
  • Children's Discovery and Innovation Institute, University of California, Los Angeles
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Ahn, S., Edmonds, B., Rajaraman, R. R., Rao, L. M., Hussain, S. A., Matsumoto, J. H., Sankar, R., Salamon, N., Fallah, A., & Nariai, H. (2024). Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric‐onset drug‐resistant epilepsy. Epilepsia, 65(8). https://doi.org/10.1111/epi.18031

Vancouver

Ahn S, Edmonds B, Rajaraman RR, Rao LM, Hussain SA, Matsumoto JH, et al. Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric‐onset drug‐resistant epilepsy. Epilepsia. 2024;65(8). doi:10.1111/epi.18031

BibTeX
@article{Ahn2024,
  author = {Ahn, Samuel and Edmonds, Benjamin and Rajaraman, Rajsekar R and Rao, Lekha M and Hussain, Shaun A and Matsumoto, Joyce H and Sankar, Raman and Salamon, Noriko and Fallah, Aria and Nariai, Hiroki},
  title = {Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric‐onset drug‐resistant epilepsy},
  journal = {Epilepsia},
  year = {2024},
  volume = {65},
  number = {8},
  doi = {10.1111/epi.18031}
}
Kostenlos starten →